A third member of a key FDA panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug, Aduhelm, CNBC has learned.

Go to Source of this post
Author Of this post:
Title Of post:

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

Author Link: {authorlink}

By admin